EUVIMEDEUVIMED entdecken
Crossref

Autophagy - related protein 5: A promising biomarker for disease activity and treatment response in lupus nephritis

Howayda El-Shinnawy, Sahar Shawky, Manal Salman, Marwa Shaaban, Ahmed Shamseldeen, Shaimaa Abdelmegied

The Egyptian journal of Immunology · 2026

DOI: 10.55133/eji.330402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Egyptian journal of Immunology, 2026. Verfasst von Howayda El-Shinnawy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Nephrology, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: Lupus Nephritis, Autophagy-Related Protein 5.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Existing biomarkers are often insufficient for adequately tracking treatment outcomes in lupus nephritis (LN). Growing evidence points to a significant role of autophagy in LN pathogenesis. This study aimed to evaluate circulating levels of autophagy-related protein 5 (ATG5) alongside its immunohistochemical expression in kidney biopsy from LN patients, and to examine its utility as a diagnostic indicator and predictor of therapeutic response. This pilot prospective research enrolled 31 patients with active LN and 9 age and sex matched normal controls. Immunohistochemical evaluation of ATG5 expression was conducted on renal biopsy specimens collected before the commencement of medication, while blood ATG5 levels were evaluated in all subjects. Serial serum ATG5 evaluations were performed at 3-month and 6-month intervals after the initiation of therapy. Circulating ATG5 levels were significantly decreased in LN patients relative to controls (cut-off ≤312.3 ng/l; AUC=0.943; sensitivity 100%; specificity 88.9%). Renal tissue ATG5 expression was detected in 96.7% of patients; strong expression identified in 87.1% using summation scoring (score >3) and in 58.1% using multiplication scoring (score >8). A biopsy summation score ≤6 predicted treatment response with AUC of 0.88, sensitivity 69.57% and 100% specificity. Treatment was associated with significant ATG5 recovery over 6 months (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus NephritisAutophagy-Related Protein 5HumansFemaleBiomarkersMaleAdultKidneyProspective StudiesTreatment OutcomeAutophagyPilot ProjectsYoung AdultImmunosuppressive Agents

Substanzen

Autophagy-Related Protein 5BiomarkersATG5 protein, humanImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Internal Medicine and Nephrology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Department of Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Zitieren

APA

El-Shinnawy, H., Shawky, S., Salman, M., Shaaban, M., Shamseldeen, A., & Abdelmegied, S. (2026). Autophagy - related protein 5: A promising biomarker for disease activity and treatment response in lupus nephritis. The Egyptian journal of Immunology. https://doi.org/10.55133/eji.330402

Vancouver

El-Shinnawy H, Shawky S, Salman M, Shaaban M, Shamseldeen A, Abdelmegied S. Autophagy - related protein 5: A promising biomarker for disease activity and treatment response in lupus nephritis. The Egyptian journal of Immunology. 2026. doi:10.55133/eji.330402

BibTeX
@article{ElShinnawy2026,
  author = {El-Shinnawy, Howayda and Shawky, Sahar and Salman, Manal and Shaaban, Marwa and Shamseldeen, Ahmed and Abdelmegied, Shaimaa},
  title = {Autophagy - related protein 5: A promising biomarker for disease activity and treatment response in lupus nephritis},
  journal = {The Egyptian journal of Immunology},
  year = {2026},
  doi = {10.55133/eji.330402}
}
Kostenlos starten →